Merck, a leading science and technology company, announced an investment of more than €50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in Darmstadt, Germany.
With its state-of-the art, flexible and modern technology, this new center of excellence will enable the packaging of more than 400 million blisters or 150 million packs annually. It will use energy-saving technologies, and forms part of Merck’s strategy to sustainably secure its leading position in healthcare manufacturing.
It is aligned with other investments across Merck’s manufacturing network worldwide and aims to further strengthen the company’s manufacturing footprint and upgrade its services for patients. Construction of the state-of-the-art 15,000 square meter packaging building is planned to be completed by the end of 2017 and expected to be operational as of mid-2018. The center will be designed to comply with the highest international GMP (Good Manufacturing Practices) quality standards.
In Darmstadt, Merck is committed to invest around € 1 billion until 2020 and this investment is part of this initiative.
|Type||New Pharmaceutical Packaging Building|
|Estimated Cost||€50 Million|
Source : merckgroup.com